Heparin-Induced Thrombocytopenia

ACCP Heparin-Induced Thrombocytopenia

ACCP GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/61601

Contents of this Issue

Navigation

Page 7 of 11

Treatment Figure 2. Isolated HIT (HIT Without Thrombosis) Normal renal function Lepirudin, argatroban, or danaparoid* (2C) HIT Complicated by Thrombosis Patients with strongly suspected or confirmed HIT with thrombosis Vitamin K if on VKA (2C) Normal renal function Renal insufficiency Argatroban, danaparoid* or lepirudin (1C) Give ≤ 5 mg warfarin only aſter platelets are ≥ 150 x 109 If HIT confirmed, overlap VKA with nonheparin for ≥ 5 d and until INR is within target range (1C) nonheparin has abated (1C) Recheck INR aſter Continue VKA for 3 months * Not available in the US. /L (1C) Argatroban (2C)

Articles in this issue

Archives of this issue

view archives of Heparin-Induced Thrombocytopenia - ACCP Heparin-Induced Thrombocytopenia